Proshares将于本周在TACIT SEC批准后本周推出三个XRP跟踪的ETF

交易所交易资金（ETF）发行人Proshares将在本周签署美国证券交易委员会（SEC）批准后，本周推出了三种XRP跟踪产品。

In a swift move following the U.S. Securities and Exchange Commission’s (SEC) tacit approval, exchange-traded funds (ETF) issuer ProShares will introduce three XRP-tracked products this week.

在美国证券交易委员会（SEC）默认批准之后，迅速采取行动，交易所交易资金（ETF）发行人Proshares将于本周推出三种XRP跟踪产品。

Its approvals for an Ultra XRP ETF (2x leverage), a Short XRP ETF and an Ultra Short XRP ETF (-2x leverage) come after the SEC had shot down several attempts to launch a Bitcoin ETF in the past seven years.

它对Ultra XRP ETF（2倍杠杆），短XRP ETF和超短XRP ETF（-2X杠杆）的批准是在过去七年中销量发射比特币ETF之后的。

The regulator also approved several XRP spot ETF applications, setting a May 22 deadline for Grayscale's filing of the SEC Chair's decision.

监管机构还批准了几个XRP Spot ETF应用程序，为5月22日的截止日期为Grayscale提交了SEC主席的决定。

ProShares’ approvals come after Monero integrators began preparations for U.S. ETF launches last month, while the applications were initially made in December.

Proshares的批准是在Monero Integrators上个月开始为US ETF推出的准备工作之后，而申请最初是在12月进行的。

The filings come a few weeks after Teucrium's 2x XRP ETF started trading earlier this month, marking the first such product in the U.S. It saw over $5 million in trading volumes on the first day, making it the firm's "most successful" launch to date.

这些文件是在Teucrium的2x XRP ETF本月初开始交易几周后，标志着美国的第一个产品在第一天就看到了超过500万美元的交易量，这使其成为迄今为止的“最成功”的发布。

Earlier this month, CME Group also added XRP futures to its largest derivatives exchange in the U.S. for launch next month, alongside BTC, ETH and SOL products.

本月初，CME Group还将XRP期货与BTC，ETH和SOL Products一起在美国最大的衍生品交易所添加了XRP期货。

The move comes after closely related company Ripple's long-standing court battle against the SEC over the token was fully concluded in March, clearing extensive regulatory headwinds for the tokens.

此举是在3月完全结束的，紧密相关的公司Ripple与SEC在代币上与SEC在代币上进行的长期法庭之战，从而消除了代币的广泛监管逆风。